Evolution of Drug-Resistant Mycobacterium tuberculosis Strains and Their Adaptation to the Human Lung Environment

A Allué-Guardia, JI García, JB Torrelles - Frontiers in Microbiology, 2021 - frontiersin.org
In the last two decades, multi (MDR), extensively (XDR), extremely (XXDR) and total (TDR)
drug-resistant Mycobacterium tuberculosis (M. tb) strains have emerged as a threat to public …

Drug-resistant strains of Mycobacterium tuberculosis: cell envelope profiles and interactions with the host

A Schami, MN Islam, JT Belisle… - Frontiers in Cellular and …, 2023 - frontiersin.org
In the past few decades, drug-resistant (DR) strains of Mycobacterium tuberculosis (M. tb),
the causative agent of tuberculosis (TB), have become increasingly prevalent and pose a …

Immunometabolism during Mycobacterium tuberculosis infection

NC Howard, SA Khader - Trends in microbiology, 2020 - cell.com
Over a quarter of the world's population is infected with Mycobacterium tuberculosis (Mtb),
the causative agent of tuberculosis (TB). Approximately 3.4% of new and 18% of recurrent …

Biomarker discovery for tuberculosis using metabolomics

Y Yu, XX Jiang, JC Li - Frontiers in molecular biosciences, 2023 - frontiersin.org
Tuberculosis (TB) is the leading cause of death among infectious diseases, and the ratio of
cases in which its pathogen Mycobacterium tuberculosis (Mtb) is drug resistant has been …

Drivers and sites of diversity in the DNA adenine methylomes of 93 Mycobacterium tuberculosis complex clinical isolates

SJ Modlin, D Conkle-Gutierrez, C Kim, SN Mitchell… - Elife, 2020 - elifesciences.org
This study assembles DNA adenine methylomes for 93 Mycobacterium tuberculosis
complex (MTBC) isolates from seven lineages paired with fully-annotated, finished, de novo …

Cell surface biosynthesis and remodeling pathways in mycobacteria reveal new drug targets

M Shaku, C Ealand, BD Kana - Frontiers in Cellular and Infection …, 2020 - frontiersin.org
Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), remains the
leading cause of death from an infectious bacterium and is responsible for 1.8 million deaths …

Elucidating the antimycobacterial mechanism of action of ciprofloxacin using metabolomics

KE Knoll, Z Lindeque, AA Adeniji, CB Oosthuizen… - Microorganisms, 2021 - mdpi.com
In the interest of developing more effective and safer anti-tuberculosis drugs, we used a
GCxGC-TOF-MS metabolomics research approach to investigate and compare the …

The Regulation of ManLAM-Related Gene Expression in Mycobacterium tuberculosis with Different Drug Resistance Profiles Following Isoniazid Treatment

M Yimcharoen, S Saikaew… - Infection and drug …, 2022 - Taylor & Francis
Introduction Tuberculosis (TB) caused by Mycobacterium tuberculosis (MTB) remains a
global health concern because of the development of drug resistance. The adaptability of …

Crystal structure of FadA2 thiolase from Mycobacterium tuberculosis and prediction of its substrate specificity and membrane‐anchoring properties

R Singh, P Kundu, VK Mishra, BK Singh… - The FEBS …, 2023 - Wiley Online Library
Tuberculosis (TB) is one of the leading causes of human death caused by Mycobacterium
tuberculosis (Mtb). Mtb can enter into a long‐lasting persistence where it can utilize fatty …

Lineage-specific differences in lipid metabolism and its impact on clinical strains of Mycobacterium tuberculosis

K Moopanar, NE Mvubu - Microbial pathogenesis, 2020 - Elsevier
Mycobacterium tuberculosis (M. tb) is the causative agent of TB and its incidences has been
on the rise since 1993. Lipid metabolism is an imperative metabolic process, which grants …